For research use only
| Cat No. | ABC-TC3179 |
| Product Type | Mouse Primary Cells |
| Cell Type | Endothelial |
| Species | C57BL/6 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Heart |
| Disease | Normal |
| Storage | Liquid Nitrogen |
C57BL/6 Mouse Cardiac Microvascular Endothelial Cells support cardiac microvascular biology, angiogenesis, and barrier assays in pathogen-free mice.
C57BL/6 Mouse Cardiac Microvascular Endothelial Cells (CMECs) are primary cells isolated from the myocardial microvasculature of pathogen-free laboratory mice. They reside in the capillary network of the cardiac microvasculature, embedded within the myocardium between cardiomyocyte bundles. Following primary culture, these cells are cryopreserved. These cardiac endothelial cells govern myocardial perfusion by regulating capillary tone via vasoactive molecules, maintain microvascular barrier integrity through junctional proteins (e.g., claudin-5), and mediate cardiomyocyte-endothelial crosstalk for metabolic exchange. CMECs express VE-cadherin, vWF, and CD31/PECAM-1. Repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | C57BL/6 Mouse Cardiac Microvascular Endothelial Cells,Mouse Cardiac Microvascular Endothelial Cells,Microvascular Endothelial Cells,ECs,C57BL/6 CMVECs |
| Species | C57BL/6 Mouse |
| Cat.No | ABC-TC3179 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Heart |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
C57BL/6 Mouse Cardiac Microvascular Endothelial Cells can be used as an in vitro model to study the pathogenesis of microvascular dysfunction in disease conditions such as diabetic cardiomyopathy and myocardial ischemia. For example, by investigating molecular pathways like hyperglycemia-induced mitochondrial fission (DRP1 activation) or ROS-mediated degradation of claudin-5 tight junctions, these cells help elucidate mechanisms of impaired perfusion, capillary leakage, and cardiomyocyte injury, aiding the development of endothelial-protective therapies to rescue cardiac microcirculation.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
These cells are recommended for culture up to 3 weeks. After 1 month in culture, cell viability is expected to be around 60%.